We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks Value Investor Highlights: Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care
Read MoreHide Full Article
For Immediate Release
Chicago, IL – January 13, 2025 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: https://www.zacks.com/stock/news/2395291/5-classic-value-stocks-for-2025
5 Classic Value Stocks for 2025
Welcome to Episode #391 of the Value Investor Podcast.
(0:15) - Finding Classic Value Stocks In The Beginning of 2025
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.
This is the first Value Investor podcast of the new year. Every year for the first episode, Tracey has run a Zacks premium stock screen called “Classic Value Stocks with Zacks #1 and #2 Rank.”
Last year, in January 2024, this screen produced only 5 stocks. That was the lowest number it had ever produced in all the years she had run it to start January.
What’s in this screen that Tracey considers one of her favorite value stock screens?
Screening for Classic Value Stocks
This screen isn’t for the faint of heart. It’s designed to be very narrow and only give you the top value stocks. And those value stocks are going to be very cheap.
It looks for stocks that are Zacks Rank #1 (Strong Buy) and #2 (Buy) stocks. These are the top 2 Zacks Ranks. Just by including the top 2 ranks, you are going to narrow the number of stocks.
The screen also looks for a Zacks Style Score for Value of A or B. Those are also the top two style scores.
The stock must be over $5 and trade with average volume over 100,000 shares a day. And it must meet all of these value fundamentals:
· Price-to-sales ratio under 1
· Price-to-book ratio under 2
· Price-to-earnings ratio under 20
· Price/Cash Flow under 20
· PEG under 1
It returned a whopping 14 stocks, which is one of the highest number for this screen for the January podcast.
Alaska Air Group had a big year in 2024 as it closed on its deal for Hawaiian Airlines in September. It now flies to over 141 destinations.
Shares of Alaska Air are up 72% over the last year but earnings are expected to rise 34% in 2025. It has an attractive forward P/E of just 11.2. Alaska Air Group is a Zacks Rank #1 (Strong Buy).
Should value investors consider an airline stock like Alaska Air Group in 2025?
Heidrick & Struggles is a small cap global staffing company. Shares of Heidrick & Struggles are up 60% over the last year but it’s still cheap.
Heidrick & Struggles trades with a forward P/E of just 15.1 as earnings are expected to rise 8% in 2025. It has a PEG ratio of 0.95. A PEG ratio under 1.0 indicates a company has both growth and value.
Heidrick & Struggles is a Zacks Rank #2 (Buy) stock.
Is it time to look at some cheap small cap stocks like Heidrick & Struggles?
USANA Health Sciences is the largest publicly held nutrition, personal health and wellness company. Even still, it’s a small cap company with a market cap of just $673 million.
On Dec 23, 2024, USANA announced it was acquiring Hiya for $205 million. Hiya makes children’s vitamins, minerals and supplements.
Shares fell 31% over the last year. USANA is cheap with a forward P/E of 11.4.
Through the end of the third quarter 2024, USANA had generated $47 million in free cash flow. It was also debt free.
USANA is a Zacks Rank #1 (Strong Buy).
With shares hitting new lows, is this a buying opportunity in USANA Health Sciences?
General Motors, the American auto manufacturer, has been a cheap stock for years even though shares are up 41% over the last year.
Earnings are expected to rise 4% in 2025 after jumping 34.6% in 2024. General Motors trades with a dirt-cheap forward P/E of just 4.8. It also has a PEG ratio of just 0.4. A PEG ratio under 1.0 indicates both growth and value.
General Motors is shareholder friendly and paying a dividend, which is yielding 0.9%. It’s a Zacks Rank #2 (Buy) stock.
Is it too late to jump into General Motors in 2025?
Fresenius Medical Care is a provider of products and services for people with chronic kidney failure. It’s a German company with a market cap of $13.3 billion. Fresenius Medical Care pays a dividend which yields 2%.
In 2025, earnings are expected to rise 26.3% but the shares are only up 8.4% in the last year. Fresenius Medical Care is cheap with a forward P/E of 11.6. It’s a Zacks Rank #1 (Strong Buy) stock.
Should a foreign company like Fresenius Medical Care be on your 2025 watch list?
What Else Should You Know about Classic Value Stocks?
Tune into this week’s podcast to find out.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks Value Investor Highlights: Alaska Air, Heidrick & Struggles, USANA Health Sciences, General Motors and Fresenius Medical Care
For Immediate Release
Chicago, IL – January 13, 2025 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: https://www.zacks.com/stock/news/2395291/5-classic-value-stocks-for-2025
5 Classic Value Stocks for 2025
Welcome to Episode #391 of the Value Investor Podcast.
Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.
This is the first Value Investor podcast of the new year. Every year for the first episode, Tracey has run a Zacks premium stock screen called “Classic Value Stocks with Zacks #1 and #2 Rank.”
Last year, in January 2024, this screen produced only 5 stocks. That was the lowest number it had ever produced in all the years she had run it to start January.
What’s in this screen that Tracey considers one of her favorite value stock screens?
Screening for Classic Value Stocks
This screen isn’t for the faint of heart. It’s designed to be very narrow and only give you the top value stocks. And those value stocks are going to be very cheap.
It looks for stocks that are Zacks Rank #1 (Strong Buy) and #2 (Buy) stocks. These are the top 2 Zacks Ranks. Just by including the top 2 ranks, you are going to narrow the number of stocks.
The screen also looks for a Zacks Style Score for Value of A or B. Those are also the top two style scores.
The stock must be over $5 and trade with average volume over 100,000 shares a day. And it must meet all of these value fundamentals:
· Price-to-sales ratio under 1
· Price-to-book ratio under 2
· Price-to-earnings ratio under 20
· Price/Cash Flow under 20
· PEG under 1
It returned a whopping 14 stocks, which is one of the highest number for this screen for the January podcast.
5 Classic Value Stocks for 2025
1. Alaska Air Group, Inc. (ALK - Free Report)
Alaska Air Group had a big year in 2024 as it closed on its deal for Hawaiian Airlines in September. It now flies to over 141 destinations.
Shares of Alaska Air are up 72% over the last year but earnings are expected to rise 34% in 2025. It has an attractive forward P/E of just 11.2. Alaska Air Group is a Zacks Rank #1 (Strong Buy).
Should value investors consider an airline stock like Alaska Air Group in 2025?
2. Heidrick & Struggles Intl, Inc. (HSII - Free Report)
Heidrick & Struggles is a small cap global staffing company. Shares of Heidrick & Struggles are up 60% over the last year but it’s still cheap.
Heidrick & Struggles trades with a forward P/E of just 15.1 as earnings are expected to rise 8% in 2025. It has a PEG ratio of 0.95. A PEG ratio under 1.0 indicates a company has both growth and value.
Heidrick & Struggles is a Zacks Rank #2 (Buy) stock.
Is it time to look at some cheap small cap stocks like Heidrick & Struggles?
3. USANA Health Sciences, Inc. (USNA - Free Report)
USANA Health Sciences is the largest publicly held nutrition, personal health and wellness company. Even still, it’s a small cap company with a market cap of just $673 million.
On Dec 23, 2024, USANA announced it was acquiring Hiya for $205 million. Hiya makes children’s vitamins, minerals and supplements.
Shares fell 31% over the last year. USANA is cheap with a forward P/E of 11.4.
Through the end of the third quarter 2024, USANA had generated $47 million in free cash flow. It was also debt free.
USANA is a Zacks Rank #1 (Strong Buy).
With shares hitting new lows, is this a buying opportunity in USANA Health Sciences?
4. General Motors Co. (GM - Free Report)
General Motors, the American auto manufacturer, has been a cheap stock for years even though shares are up 41% over the last year.
Earnings are expected to rise 4% in 2025 after jumping 34.6% in 2024. General Motors trades with a dirt-cheap forward P/E of just 4.8. It also has a PEG ratio of just 0.4. A PEG ratio under 1.0 indicates both growth and value.
General Motors is shareholder friendly and paying a dividend, which is yielding 0.9%. It’s a Zacks Rank #2 (Buy) stock.
Is it too late to jump into General Motors in 2025?
5. Fresenius Medical Care AG (FMS - Free Report)
Fresenius Medical Care is a provider of products and services for people with chronic kidney failure. It’s a German company with a market cap of $13.3 billion. Fresenius Medical Care pays a dividend which yields 2%.
In 2025, earnings are expected to rise 26.3% but the shares are only up 8.4% in the last year. Fresenius Medical Care is cheap with a forward P/E of 11.6. It’s a Zacks Rank #1 (Strong Buy) stock.
Should a foreign company like Fresenius Medical Care be on your 2025 watch list?
What Else Should You Know about Classic Value Stocks?
Tune into this week’s podcast to find out.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year. Amazingly, they soared with average gains of +44.9%, +48.4% and +55.2% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
Tracey Ryniec is the Value Stock Strategist for Zacks.com. She is also the Editor of the Insider Trader and Value Investor services. You can follow her on twitter at @TraceyRyniec and she also hosts the Zacks Market Edge Podcast on iTunes.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Click here for your free subscription to Profit from the Pros.
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch/
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/performance
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.